Cardiovascular diseases (CVDs) have become a serious threat to human life and health.
Though many drugs acting via different mechanism of action are available in the market as …

Nanomedicines refers to nanotechnology inspired pharmaceutical products often referred to
as 'nanopharmaceuticals.'It has displayed commendable potential in enhancing therapeutic …

In the field of targeted drug delivery, the effects of size and morphology of drug nanocarriers
are of great importance and need to be discussed in depth. To be concise, among all the …

Recent studies have revealed the effects of shape on in vivo nanoparticle circulation,
distribution, extravasation, and cellular uptake. Morphology is therefore becoming a key …

Nanoparticle-based systems are extensively investigated for drug delivery. Among others,
with superior biocompatibility and enhanced targeting capacity, albumin appears to be a …

Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …

Cardiovascular disease (CVD) is the leading cause of death worldwide. A search for more
effective treatments of CVD is increasingly needed. Major advances in nanotechnology …

Delivering therapeutic agents efficiently to inflamed regions remains an intractable
challenge following myocardial ischemia-reperfusion injury (MI/RI) due to the transient …

A large majority of cardiovascular nanomedicine research has focused on fabricating
designer nanoparticles for improved targeting as a means to overcome biological barriers …

Amyotrophic lateral sclerosis (ALS) is a devasting neurodegenerative disease with no cure
to date. Therapeutic agents used to treat ALS are very limited, although combined therapies …